US Patent Issued to REATA PHARMACEUTICALS on July 1 for "C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof" (Texas Inventors)

ALEXANDRIA, Va., July 3 -- United States Patent no. 12,344,631, issued on July 1, was assigned to REATA PHARMACEUTICALS INC. (Irving, Texas).

"C17 polar-substituted heteroaromatic synthetic triterpenoids and methods of use thereof" was invented by Xin Jiang (Coppell, Texas), Christopher F. Bender (Garland, Texas), Ha Do (Irving, Texas), Haizhou Sun (Irving, Texas) and Melean Visnick (Irving, Texas).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are compounds of the formula:wherein the variables are defined herein. Also provided are pharmaceutical compositions thereof. In some aspects, the compounds and compositions provided herein may be used as antioxidant inflammation modulators. In some as...